Stock Taper 
Hinge Health, Inc., founded in 2012 and based in San Francisco, develops healthcare software for musculoskeletal care, including injury, pain, and rehab, along with administrative and support services.
A digital platform offering personalized virtual physical therapy, AI motion tracking, and clinical support via a mobile app to employers and health plans, aiming to reduce costs and improve musculoskeletal health.
Hinge Health's first quarterly earnings report as a public company for Q2 2025 significantly exceeded analyst expectations, causing the stock to surge by over 50%. The company reported a 55% year-over-year revenue increase to $139.1 million and a non-GAAP EPS of $0.33, well above the anticipated $0.09. This standout performance, coming shortly after its May 2025 IPO, captured significant investor and media attention.
In a significant move to broaden its global footprint, Hinge Health acquired a major European competitor in August 2025. This acquisition marks the company's first major international expansion, aiming to tap into the largely underserved European market for digital musculoskeletal (MSK) care and solidify its position as an industry leader.
Argent Capital Management LLC purchased a new stake in Hinge Health Inc. (NYSE: HNGE) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 34,721 shares of the company's stock, valued at approximately $3,376,000. Several other large investors have also
Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial mar
Hinge Health Inc. (NYSE: HNGE - Get Free Report) reached a new 52-week high during trading on Monday. The stock traded as high as $99.73 and last traded at $98.6050, with a volume of 973880 shares traded. The stock had previously closed at $97.67. Wall Street Analyst Weigh In A number of equities research analysts have
Hinge Health Inc. (NYSE: HNGE - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday. The company traded as high as $97.95 and last traded at $94.3050, with a volume of 157292 shares traded. The stock had previously closed at $92.45. Analyst Ratings Changes Several brokerages recently issued reports on HNGE. Barclays
The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
 OSCR | $31.79 | COMPARE |
 PRAX | $284.60 | COMPARE |
 IMVT | $33.50 | COMPARE |
 LNTH | $100.15 | COMPARE |
 INDV | $35.85 | COMPARE |
 VKTX | $29.24 | COMPARE |
 DYN | $15.29 | COMPARE |
 WGS | $76.14 | COMPARE |
